Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Closed Complete Annotated Genome Sequences of Five Haemophilus influenzae Biogroup aegyptius Strains.

Phillips ZN, Tram G, Jennings MP, Atack JM.

Microbiol Resour Announc. 2019 Nov 7;8(45). pii: e01198-19. doi: 10.1128/MRA.01198-19.

2.

Chlamydia-infected macrophages are resistant to azithromycin treatment and are associated with chronic oviduct inflammation and hydrosalpinx development.

Harvie MC, Carey AJ, Armitage CW, O'Meara CP, Peet J, Phillips ZN, Timms P, Beagley KW.

Immunol Cell Biol. 2019 Nov;97(10):865-876. doi: 10.1111/imcb.12285. Epub 2019 Sep 11.

PMID:
31348541
3.

Phase-variable bacterial loci: how bacteria gamble to maximise fitness in changing environments.

Phillips ZN, Tram G, Seib KL, Atack JM.

Biochem Soc Trans. 2019 Aug 30;47(4):1131-1141. doi: 10.1042/BST20180633. Epub 2019 Jul 24. Review.

PMID:
31341035
4.

Phasevarions of bacterial pathogens - phase-variable epigenetic regulators evolving from restriction-modification systems.

Phillips ZN, Husna AU, Jennings MP, Seib KL, Atack JM.

Microbiology. 2019 Sep;165(9):917-928. doi: 10.1099/mic.0.000805. Epub 2019 Apr 17.

PMID:
30994440
5.

Analysis of Invasive Nontypeable Haemophilus influenzae Isolates Reveals Selection for the Expression State of Particular Phase-Variable Lipooligosaccharide Biosynthetic Genes.

Phillips ZN, Brizuela C, Jennison AV, Staples M, Grimwood K, Seib KL, Jennings MP, Atack JM.

Infect Immun. 2019 Apr 23;87(5). pii: e00093-19. doi: 10.1128/IAI.00093-19. Print 2019 Mar.

6.

Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial.

Pandey M, Powell J, Calcutt A, Zaman M, Phillips ZN, Ho MF, Batzloff MR, Good MF.

Sci Rep. 2017 Oct 23;7(1):13786. doi: 10.1038/s41598-017-14157-7.

7.

Enhancing Vaccine Efficacy by Engineering a Complex Synthetic Peptide To Become a Super Immunogen.

Nordström T, Pandey M, Calcutt A, Powell J, Phillips ZN, Yeung G, Giddam AK, Shi Y, Haselhorst T, von Itzstein M, Batzloff MR, Good MF.

J Immunol. 2017 Oct 15;199(8):2794-2802. doi: 10.4049/jimmunol.1700836. Epub 2017 Sep 13.

8.

Novel platform technology for modular mucosal vaccine that protects against streptococcus.

Zaman M, Ozberk V, Langshaw EL, McPhun V, Powell JL, Phillips ZN, Ho MF, Calcutt A, Batzloff MR, Toth I, Hill GR, Pandey M, Good MF.

Sci Rep. 2016 Dec 15;6:39274. doi: 10.1038/srep39274.

Supplemental Content

Loading ...
Support Center